TLDR
- Quantum Computing Inc. (QUBT) reported Q2 revenue of $5.6 million, up over 9,000% year over year from just $61,000.
- QUBT traded near $8.91 on Aug. 21 as seven quantum computing stocks rallied together.
- Net loss narrowed to $11.8 million from $36.5 million, largely due to shrinking warrant derivative losses, not core profitability.
- Six different catalysts drove the broader sector rally, including a new BMO price target on D-Wave and an IBM cryogenic milestone.
- Analyst consensus on QUBT is Hold, with an average price target of $18.33 and revenue beating estimates at $5.55 million vs. $5.15 million expected.
Quantum Computing Inc. reported Q2 revenue of $5.6 million, a jump of more than 9,000% from the $61,000 it posted in the same quarter a year ago. The stock opened at $8.91 on Aug. 21, as part of a broader rally across quantum computing names.
The revenue growth came from photonics product sales to government, educational, and commercial customers. Revenue also rose 51% sequentially from Q1’s $3.7 million.
That headline number is eye-catching. But the business behind it is still very small, and most of the bottom-line improvement came from a shrinking paper loss on warrant derivatives rather than the core business turning a profit.
Net loss narrowed to $11.8 million from $36.5 million a year earlier. QUBT ended the quarter with a $42.5 million order backlog and $1.3 billion in cash, giving it years of runway.
The quarter also included QUBT’s acquisition of NHanced Semiconductors, which launched a second chip fabrication facility. That deal pushed operating expenses up 114% year over year to $21.8 million.
QUBT reported a loss of $0.05 per share, missing the consensus estimate of $0.03. But revenue of $5.55 million came in above the $5.15 million analysts expected.
Sector-Wide Rally, Multiple Catalysts
QUBT wasn’t alone on Aug. 21. D-Wave (QBTS), Rigetti (RGTI), IonQ (IONQ), Infleqtion (INFQ), IQM (IQMX), and IBM all moved higher the same morning.
Each had its own catalyst, or none at all. D-Wave gained up to 7% after BMO Capital Markets started coverage with an Outperform rating and a $35 price target. Rigetti climbed 9.6% even though BMO’s note never mentioned it. IonQ rose 7.5% after signing a non-binding agreement to join a Canadian government quantum cloud platform. IBM advanced 2% after linking two cryogenic modules, a step toward its 2029 fault-tolerant quantum target.
Quantum stocks increasingly trade as a single basket. When one name gets a bullish headline, the others tend to follow, regardless of whether the news applies to them.
Reading the Numbers Right
Infleqtion is a good example of how these figures can mislead. The company first reported Q2 revenue up 116% to $12.6 million, then revised that to $13.5 million, a 157% increase, in an amended SEC filing. Most of the coverage that moved the stock that week never caught the revision.
A 9,000% revenue jump sounds like a moonshot. When the prior-year figure is $61,000, the math is straightforward.
Landscape Capital Management bought 381,046 QUBT shares in Q2, valued at about $3.7 million. Institutional investors hold 4.26% of the company overall.
Analyst ratings stand at four Buy, two Hold, and one Sell, with a consensus Hold rating and an average price target of $18.33. The 52-week range runs from $6.18 to $25.84.
IQM has told investors to expect most of its 2026 revenue in Q4, tied to system deliveries inside its EUR 102 million order backlog. D-Wave has guided to two to three full system sales per year starting in 2027.
Stop guessing and start investing with confidence. KnockoutStocks gives you the AI insights, market intelligence, and stock research you need to spot opportunities, cut through the noise, and make smarter investment decisions — all in one powerful platform.
Sign up today and get 50% OFF full access to our premium stock picks.
Simply use coupon code SPECIAL50 at checkout to claim your exclusive discount.
